High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
about
Cancer stem cell metabolismTargeting hypoxic response for cancer therapyBalancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancerCD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotypeNADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patientsGermline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer.Hallmarks of cancer stem cell metabolism.Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.Scaling and automation of a high-throughput single-cell-derived tumor sphere assay chip.Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine.Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs).Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics.Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy.Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.Cancer stemness and progression: mitochondria on the stage.Mitochondrial mass and DNA repair in breast cancer stem cells.A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in glioma.A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells.Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.Cytotoxic stress induces transfer of mitochondria-associated human endogenous retroviral RNA and proteins between cancer cells.Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization.Functional Isolation of Tumor-Initiating Cells using Microfluidic-Based Migration Identifies Phosphatidylserine Decarboxylase as a Key Regulator.Transcriptional Regulation of Stem Cell and Cancer Stem Cell Metabolism.The new anticancer era: Tumor metabolism targeting.Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Cancer Stem Cell Metabolism and Potential Therapeutic Targets.A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RXDoxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot StudyIncreased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
P2860
Q26746123-BF115822-056D-4266-8208-27FE7AB28431Q26767351-E9CFB8AD-8F09-4D05-B56E-6C1D3057E1EEQ28070584-3CD3A0C4-3BA3-49F0-B07F-A71362CEFA93Q28072798-E7065430-5B8C-4D0A-99C0-2911E2983EF3Q30353497-89E6E707-A15F-4702-8FE0-1C3942EC2E2FQ33591293-42394CE5-FCF9-4A3C-B60F-FB1A73A3DA49Q35793332-14E608FC-3F27-4BE4-8B9E-7261AC525223Q37528206-1D805082-3652-4881-8580-6AED5B20B4B6Q37619695-982BC540-1B54-4001-B831-71E984C373CDQ38756331-F1DD56BD-20BD-4262-BEE2-5200F806A2B5Q38842974-5185F3D8-6CD6-4169-97BF-4D2AEBC5483DQ39138664-D4541364-8537-4D44-8DAE-143892F2DC3DQ39503289-2C09EA39-A428-48D4-8686-EE87200684EAQ41347692-D66BD53E-3E29-4832-81A6-62679E3A187FQ41817959-7754C541-5600-434E-876E-36237D5942FAQ41911837-78436AD5-F000-4F39-A66F-30D259A50F1BQ41912547-33B6D99A-AD1E-481B-A08F-4FDB4C20241CQ41944791-A9E500B9-35D4-4FC1-80A1-615B5D0A44C5Q41991215-BEDAC1B7-899D-4F9E-8074-BC315CF3EF54Q42552304-B43B6E65-54BB-453A-A589-F9DD8D3E8FEAQ42601782-B90A665A-2972-49E2-BE76-B3D99172D91BQ42672085-DCF7A58E-AC66-4C32-9AE2-30BC88A8CB58Q44423833-187CF544-67F6-436B-AB70-0780CA8157A5Q46260444-0350B676-05AB-46DE-95AA-3AA4637FD8DCQ46312467-918C3C3A-8DDB-4C02-B183-6E4EF9854FF6Q47140969-5DBCA03D-6525-489B-9CF5-42091D240F82Q47289203-C6DAB764-0072-49C5-BAFD-CD1C463E2373Q47585107-F56AD3BA-F134-40DC-83D2-F6F5B0B1BD7CQ48022535-6B7BFFAC-5A28-4D1A-B580-A8C0185F3F30Q48508211-18CAFA46-06C5-4BF3-B15D-338C7F300461Q50051205-B7EA3D58-BF61-41F7-8416-603DE9422D33Q50318630-EB329DA6-650F-4769-98D0-A2BBF38959FBQ51768229-DFD2FDC0-0B31-475F-8753-2E9FB82C9C0EQ52726871-FA7599B8-7495-4A3C-8127-0F6647EC88D2Q53682156-061DAA10-2693-449E-879C-2D98BC1878ABQ55254924-04460C61-5F3D-4EFF-ADD2-8EC901BA60FFQ55296899-24C40DCA-C28B-418C-A9AF-6A7C894A46E4Q57148983-E0765D70-CDA6-498B-9F1D-A637CFA177CCQ58569832-0AEEFEDA-154E-4137-8AF6-B076F17CE151Q58788865-C4C3B288-857B-4487-B363-ECC4929FE06B
P2860
High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
High mitochondrial mass identi ...... ells that are chemo-resistant.
@ast
High mitochondrial mass identi ...... ells that are chemo-resistant.
@en
type
label
High mitochondrial mass identi ...... ells that are chemo-resistant.
@ast
High mitochondrial mass identi ...... ells that are chemo-resistant.
@en
prefLabel
High mitochondrial mass identi ...... ells that are chemo-resistant.
@ast
High mitochondrial mass identi ...... ells that are chemo-resistant.
@en
P2860
P356
P1433
P1476
High mitochondrial mass identi ...... ells that are chemo-resistant.
@en
P2093
Gillian Farnie
P2860
P304
30472-30486
P356
10.18632/ONCOTARGET.5401
P407
P577
2015-09-30T00:00:00Z